patients who undergoing painless hysteroscopy
Conditions
Interventions
0.10mg/kg nalbuphine group:patients' somatokinetic response when the hysteroscope enter cervix
0.15mg/kg nalbuphine group:patients' somatokinetic response when the hysteroscope enter cervix
0.20mg/kg nalbuphine group:patients' somatokinetic response when the hysteroscope enter cervix
Sponsors
The First Affiliated Hospital of Shantou University Medical College
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.patients who undergoing elective painless hysteroscopy 2.age 18-65 years old 3.ASA Grade ?-? 4.BMI18-28kg/m2 5.without respiratory diseases and normal airway assessment before surgery
Exclusion criteria
Exclusion criteria: 1.refused to sign the informed consent 2.allergic to the experimental drug 3.complicated with severe circulatory, respiratory, hepatic, urinary, neurological system and mental diseases 4.long-term use of opioids, painkillers, sedatives, or a history of alcohol abuse 5.patients with OSAS 6.with chronic pelvic pain before sugery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| somatokinetic response; | — |
Secondary
| Measure | Time frame |
|---|---|
| NRS scale;Ramsay Scale; | — |
Countries
China
Contacts
Public ContactZhaodong Zeng
The First Affiliated Hospital of Shantou University Medical College
Outcome results
None listed